Skip to content

Sharing successes, challenges and daily happenings in the Department of Medicine

kbennett

Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

ARTICLE: Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus AUTHORS: Thomas Dörner, Yoshiya Tanaka, Ernst… Read More »Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

ARTICLE: Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients AUTHORS: Andrew H Karaba, Jake D Kim, Teresa P-Y Chiang, Jennifer… Read More »Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients